Skip Navigation

Cardiovascular Research 2001 49(3):671-680; doi:10.1016/S0008-6363(00)00270-4
© 2001 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schmeisser, A.
Right arrow Articles by Daniel, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmeisser, A.
Right arrow Articles by Daniel, W. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2001, European Society of Cardiology

Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel® under angiogenic conditions

Alexander Schmeissera,1,*, Christoph D. Garlichs1,b, Hong Zhangb, Saeed Eskafib, Christiane Graffyb, Josef Ludwigb, Ruth H. Strassera and Werner G. Danielb

aDepartment of Cardiology, Technical University of Dresden, Heart Center Dresden, Fetscherstr. 76, D-01307 Dresden, Germany
bDivision of Molecular Cardiology, Department of Cardiology, University Erlangen-Nuernberg, Oestliche Stadtmauerstr. 29, D-91054 Erlangen, Germany

* Corresponding author. Tel.: +49-351-450-1704; fax: +49-351-450-1702 alexanderschmeis{at}t-online.de

Objectives: It has been shown that circulating human non-adherent CD34+ cells coexpressing vascular endothelial growth factor (VEGF)-R2 and AC133 have the capacity to differentiate into adherent mature endothelial cells. However, prior studies have demonstrated that a much bigger subset of primary adherent mononuclear cells can also form endothelial progenitor cells (EPC). To determine the origin of the latter cell population we tested the hypothesis: do monocytes as a firmly adherent and plastic cell type have the potential to differentiate into an endothelial phenotype. Methods: CD34/CD14+ monocytes were isolated from human peripheral blood by adherence separation and magnetic bead selection (purity <90%) and cultured on fibronectin-coated plastic dishes (medium containing VEGF 10 ng/ml, basic fibroblast growth factor (bFGF) 2 ng/ml, insulin like growth factor (IGF-1) 1 ng/ml, 20% fetal calf serum). Results: After 2 weeks of culture, using fluorescence activated cell analysis we observed a new expression of the endothelial markers von Willebrand factor (vWf), VE-cadherin (VE) and ec-NOS in 45.2, 12.4 and 9.8% of the cells, respectively. The proportion of cells expressing these markers further increased after 4 weeks (94.2, 89.7 and 58.8% of these cells, respectively). The proportion of CD45 expressing cells remained unchanged during this period. However, after 14 days the specific macrophage antigen CD68 was newly expressed in 62% of the analysed cells with a further increase to 90% after 28 days of culture. In three-dimensional gel (Matrigel®) the formation of cord- and tubular-like structures was observed. Conclusion: The present data indicate that under angiogenic stimulation macrophages develop an endothelial phenotype with expression of specific surface markers and even form cord- and tubular-like structures in vitro suggesting that this cell population may be recruited for vasculogenesis.

KEYWORDS bFGF, basic fibroblast growth factor; EC, endothelial cells; EPC, endothelial progenitor cells; FACS, fluorescence activated cell analysis; FCS, fetal calf serum; Flk-1, fetal liver kinase-1; Flt-1, fms-like tyrosine kinase-1; HSC, hematopoietic stem cells; HUVEC, human umbilical vein endothelial cells; IGF-1, insulin like growth factor; Mo, monocytes; ox-LDL, oxidized low density lipoprotein; VE, VE-cadherin; VEGF, vascular endothelial growth factor; vWf, von Willebrand factor


1 These authors have contributed equally to this work.

* Presented in part at the 72nd Scientific Session of the American Heart Association, Atlanta, GA, November 7–10, 1999, and published in abstract form [Circulation 100 (1999) I-405]. During the review process of this manuscript similar findings where published by Fernandez Pujol et al. [Differentiation 65 (2000) 287–300].


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Vasc MedHome page
D. P Sieveking and M. K. Ng
Cell therapies for therapeutic angiogenesis: back to the bench
Vascular Medicine, May 1, 2009; 14(2): 153 - 166.
[Abstract] [PDF]


Home page
Cancer Res.Home page
B. Li, A. Vincent, J. Cates, D. M. Brantley-Sieders, D. B. Polk, and P. P. Young
Low Levels of Tumor Necrosis Factor {alpha} Increase Tumor Growth by Inducing an Endothelial Phenotype of Monocytes Recruited to the Tumor Site
Cancer Res., January 1, 2009; 69(1): 338 - 348.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. Obi, K. Yamamoto, N. Shimizu, S. Kumagaya, T. Masumura, T. Sokabe, T. Asahara, and J. Ando
Fluid shear stress induces arterial differentiation of endothelial progenitor cells
J Appl Physiol, January 1, 2009; 106(1): 203 - 211.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. K. Hirschi, D. A. Ingram, and M. C. Yoder
Assessing Identity, Phenotype, and Fate of Endothelial Progenitor Cells
Arterioscler. Thromb. Vasc. Biol., September 1, 2008; 28(9): 1584 - 1595.
[Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
E. M. Pasini, M. Kirkegaard, D. Salerno, P. Mortensen, M. Mann, and A. W. Thomas
Deep Coverage Mouse Red Blood Cell Proteome: A First Comparison with the Human Red Blood Cell
Mol. Cell. Proteomics, July 1, 2008; 7(7): 1317 - 1330.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Z. Behm, B. A. Kaufmann, C. Carr, M. Lankford, J. M. Sanders, C. E. Rose, S. Kaul, and J. R. Lindner
Molecular Imaging of Endothelial Vascular Cell Adhesion Molecule-1 Expression and Inflammatory Cell Recruitment During Vasculogenesis and Ischemia-Mediated Arteriogenesis
Circulation, June 3, 2008; 117(22): 2902 - 2911.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
T. J. Povsic and P. J. Goldschmidt-Clermont
Review: Endothelial progenitor cells: markers of vascular reparative capacity
Therapeutic Advances in Cardiovascular Disease, June 1, 2008; 2(3): 199 - 213.
[Abstract] [PDF]


Home page
J. Immunol.Home page
R. T. van Beem, W. A. Noort, C. Voermans, M. Kleijer, A. ten Brinke, S. M. van Ham, C. E. van der Schoot, and J. J. Zwaginga
The Presence of Activated CD4+ T Cells Is Essential for the Formation of Colony-Forming Unit-Endothelial Cells by CD14+ Cells
J. Immunol., April 1, 2008; 180(7): 5141 - 5148.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
M. ANGHELINA, A. SCHMEISSER, P. KRISHNAN, L. MOLDOVAN, R.H. STRASSER, and N.I. MOLDOVAN
Migration of Monocytes/Macrophages In Vitro and In Vivo Is Accompanied by MMP12-dependent Tunnel Formation and by Neovascularization
Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 209 - 216.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.